Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001741533-26-000002

CHIEF MEDICAL OFFICER sold 40,000 shares at an average $44.82 ($1,792,940)

  • CHIEF MEDICAL OFFICER acquired 40,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Paolini John F. · CHIEF MEDICAL OFFICER

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Exercise or conversion : show line 1 in the form 10b5-1 +40,000 $10.36 $414,400 101,324 D
2026-03-02 Sale : show line 2 in the form 10b5-1 −12,063 $44.20 $533,185 89,261 D
2026-03-02 Sale : show line 3 in the form 10b5-1 −22,223 $44.88 $997,368 67,038 D
2026-03-02 Sale : show line 4 in the form 10b5-1 −5,714 $45.92 $262,387 61,324 D
Open-market sales · 40,000 sh · avg $44.82 · $1,792,940

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-02 Exercise or conversion : show line 5 in the form 10b5-1 Share Option −40,000 58,424 D
Loading xslF345X05/form4-03042026_090352.xml…